Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Artificial Pancreas Device System Market Report: Trends, Forecast and Competitive Analysis
... medical centers. The global artificial pancreas device system market is expected to grow with a CAGR of 13% to 15% from 2023 to 2028. The major drivers for this market are increasing prevalence of diabetes, ... Read More
-
Global Food Intolerance Products Market Research Report 2022-2032
... According to a recently published report by Fatpos Global on “Food Intolerance Products Market” delivers a detailed overview of the market in terms of market segmentation by material type, by thickness, by application, by transparency, ... Read More
-
United Kingdom Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... the worst diabetes condition in Europe, with the most overweight and obese adults, according to the WHO. As a result, United Kingdom, have more people than ever with diabetes. Diabetes is a chronic disease that ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... a defect in insulin secretion and sensitivity, whereby the β-cells in the pancreas fail to secrete sufficient amounts of insulin and cells fail to uptake adequate amounts of insulin due to loss of sensitivity, commonly ... Read More
-
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia - Drugs In Development, 2022, provides an overview of the Hyperglycemia (Metabolic Disorders) pipeline landscape. Hyperglycemia is a condition that occurs when blood glucose levels get ... Read More
-
Tonometry Device Market, by DeviceType (Applanation Tonometers, Pascal Dynamic Contour Tonometers, Rebound Tonometers, Indentation Tonometers), by Application (Heart failure, Hypertension, Arteriosclerosis, Others (COPD, and Diabetes etc.)), by End User (Hospitals, Specialty Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tonometry means "to measure pressure" while applanation means "to flatten out." Radial artery ... Read More
-
Type 2 Diabetes Treatment: Global Market Outlook
... 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based ... Read More
-
MENAT Syringe Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Syringe Type (Luer Lock Syringes, Glass Syringes, Luer Slip Syringes, and Others), Application (Aesthetics, Human Health, Lab / Industrial, and Others), Usability (Sterilizable/Reusable Syringes and Disposable Syringes), and End User (Hospitals & Clinics, Blood Collection Centers, Diabetic Care Centers, and Others)
... (Sterilizable/Reusable Syringes and Disposable Syringes), and End User (Hospitals & Clinics, Blood Collection Centers, Diabetic Care Centers, and Others) The MENAT syringe market is expected to grow from US$ 882.66 million in 2021 to US$ ... Read More
-
Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
2023 Global Forecast for Blood Glucose Monitoring System Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
Point of Care/ Rapid Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027
... diagnostics market is projected to reach USD 75.5 Billion by 2027 from USD 45.4 Billion in 2022, at a CAGR of 10.7% during the forecast period. The growth in the point-of-care and rapid diagnostics market ... Read More
-
Digital Therapeutics Market Size By Component (Software, Device) By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioral Health, Hypertension, Insomnia) By Sales Channel (Business-to-business (B2B), Business-to-consumers (B2C)), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Forecast, 2023-2032 Global Digital Therapeutics Market is slated to expand steadily through 2032 owing to the surging adoption of digital therapeutics in the healthcare sector and its potential to deliver better quality of care. Additionally, ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
... market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the growing ... Read More
-
Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Surgical Devices), By Method, By Wound Type (Pressure Ulcers, Diabetic Foot Ulcers), By End-use, By Mode of Purchase, By Region, And Segment Forecasts, 2023 - 2030
... 2023 - 2030 Wound Debridement Market Growth & Trends The global wound debridement market size is anticipated to reach USD 7.17 billion by 2030, expected to expand at a CAGR of 6.2% during the forecast ... Read More
-
Global Insulin Pump Market Size, Trends & Growth Opportunity, By Pump Type, By Application, By Disease Indication, and By Region Forecast till 2027.
... US$ 4.79 Billion in 2021. The Global Insulin Pump Market is anticipated to develop at a CAGR of 8.7% during the forecast period to US$ 20.04 Billion by the end of year 2027. The Qualiket ... Read More
-
Global Diabetic Retinopathy Market - 2022-2029
... 6.9% during the forecast period (2022-2029). Diabetes mellitus harms the retina's blood vessels, referred to as diabetic retinopathy (DR). There are two different types of this condition: non-proliferative DR and proliferative or advanced DR. It ... Read More
-
2023 Global Forecast for Insulin and antidiabetic agents (2023-2028 Outlook)-Manufacturing & Markets Report
... on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2028. Product shipments include the total value of all products ... Read More
-
Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region - Global Forecast to 202
... home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by ... Read More
-
Global Diabetic Neuropathy Market - 2022-2029
... CAGR of 6.40% during the forecast period (2022-2029). Diabetic neuropathy is nerve deterioration caused by diabetes. High blood sugar (glucose) injures nerves throughout the body. Most frequently, Diabetic neuropathy damages nerves in the legs and ... Read More
-
Diabetic Foot Ulcers Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hos
... Clinics, Others) and Segment Forecast, 2022-2027 Summary The diabetic foot ulcers market size was valued at US$ 4,740.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% ... Read More
-
U.S. Diabetic Neuropathy Market, by Drug (Tricyclic Antidepressants (Amitriptyline, Nortyptyline, Imipramine, Desipramine), SSRI (Paroxetine, Citalopram), Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine), Opioids (Tramadol, Tapentadol, Oksikodon), SNRIs (Duloxetine), Other Drugs (Capsaicin, Lidocaine, Botilinum Toxin)) by Type (Peripheral Neuropathy, Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetic neuropathy is ... Read More
-
2023 Global Forecast for Artificial Pancreas Device System (Adps) (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
Syringe Market, By Usage (Sterilizable/Reusable Syringes, Disposable Syringes, and Prefilled Syringes), By Application (Insulin Syringes, Botox, Osteoarthritis, Human Growth Hormone and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 A syringe is the tube with a plunger that usually connects to a needle. It is widely used to inject fluid into the body ... Read More
-
Medical Nutrition Market, by Nutrition Type (Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acids, Fibers, Minerals, and Others), by Patient Type (Infant Nutrition Adult Nutrition, and Geriatric Nutrition ), by Indication (Diabetes, Cancer, Gastrointestinal diseases, Metabolic Syndromes, and Others ), by Route of Administration (Oral , Enteral, and Parenteral), by End User (Hospitals, Home Care Setting, Long Term Care, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Syndromes, and Others ), by Route of Administration (Oral , Enteral, and Parenteral), by End User (Hospitals, Home Care Setting, Long Term Care, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, ... Read More
Research Assistance
